|
SATELLITE SYMPOSIUM OF THE RESPIRATORY ONCOLOGY
RECENT ADVANCES IN LUNG CANCER: NEW TREATMENT OPTIONS LEADING TO NEW HOPE
{{ getTitle(live) }}
{{ toDate(live.liveStartDate) }}
{{ toTime(live.liveStartDate) }} - {{ toTime(live.liveEndDate) }}
{{ getNotification(live) }}
SCIENTIFIC PROGRAM
Chairs:
Prof. Dr. Johan Vansteenkiste, UZ Leuven
Prof. Dr. Anne Sibille, CHU Liège
19h30 | Introduction |
19h40 | CNS disease in lung cancer: How active are targeted and immunotherapies ? |
Dr. Lizza Hendriks (pre-recorded), Maastricht UMC+, Netherlands | |
20h00 | Panel discussion and Q&A on CNS disease in lung cancer: How active are targeted and immunotherapies ? |
Prof. Dr. Johan Vansteenkiste, Prof. Dr. Lore Decoster & Prof. Dr. Anne Sibille | |
20h15 | Immunotherapy: Is it too early for early stage NSCLC ? |
Prof. Dr. Lore Decoster, UZ Brussels | |
20h40 | ALK translocated NSCLC: Few patients, but therapies galore ! |
Prof. Dr. Solange Peters (virtual), CHU Vaudois, Lausanne, Switzerland. | |
21h05 | Closing |
SCIENTIFIC PROGRAM
Chairs:
Prof. Dr. Johan Vansteenkiste, UZ Leuven
Prof. Dr. Anne Sibille, CHU Liège
19h30 | Introduction |
19h40 | CNS disease in lung cancer: How active are targeted and immunotherapies ? |
Dr. Lizza Hendriks (pre-recorded), Maastricht UMC+, Netherlands | |
20h00 | Panel discussion and Q&A on CNS disease in lung cancer: How active are targeted and immunotherapies ? |
Prof. Dr. Johan Vansteenkiste, Prof. Dr. Lore Decoster & Prof. Dr. Anne Sibille | |
20h15 | Immunotherapy: Is it too early for early stage NSCLC ? |
Prof. Dr. Lore Decoster, UZ Brussels | |
20h40 | ALK translocated NSCLC: Few patients, but therapies galore ! |
Prof. Dr. Solange Peters (virtual), CHU Vaudois, Lausanne, Switzerland. | |
21h05 | Closing |